PUBLISHER: The Business Research Company | PRODUCT CODE: 1889611
PUBLISHER: The Business Research Company | PRODUCT CODE: 1889611
Viral vector packaging services involve specialized processes that generate viruses engineered to safely and efficiently deliver genetic material into target cells. These services produce high-quality, functional viral vectors for use in gene therapy, vaccine development, and biomedical research. They facilitate the effective advancement of therapeutic innovations and research tools, while ensuring scalable production that meets clinical and commercial needs and complies with strict safety and regulatory requirements.
The primary service types in viral vector packaging include contract development and manufacturing services, custom viral vector production, ready-to-use viral vectors, and quality control and testing services. Contract development and manufacturing services are outsourced solutions in which specialized providers design, develop, and produce products for clients, typically within pharmaceutical, biotechnology, or related sectors. These services encompass various vector types such as adenoviral vectors, lentiviral vectors, adeno-associated viral vectors, and retroviral vectors, and employ multiple technologies, including transfection-based techniques, packaging systems, viral packaging cell lines, and purification methods. They operate across small-scale, medium-scale, and large-scale production levels and support end users involved in gene therapy, cell therapy, vaccination, and research and development.
Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the healthcare sector, particularly in the supply of critical medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are facing higher costs for imported surgical instruments, imaging equipment, and consumables such as syringes and catheters, many of which have limited domestic alternatives. These increased costs are straining healthcare budgets, leading some providers to delay equipment upgrades or pass on expenses to patients. Additionally, tariffs on raw materials and components are disrupting the production of essential drugs and devices, causing supply chain bottlenecks. In response, the industry is diversifying sourcing strategies, boosting local manufacturing where possible, and advocating for tariff exemptions on life-saving medical products.
The viral vector packaging services market research report is one of a series of new reports from The Business Research Company that provides viral vector packaging services market statistics, including the viral vector packaging services industry global market size, regional shares, competitors with the viral vector packaging services market share, detailed viral vector packaging services market segments, market trends, and opportunities, and any further data you may need to thrive in the viral vector packaging services industry. This viral vector packaging services market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.
The viral vector packaging services market size has grown rapidly in recent years. It will grow from $1.45 billion in 2024 to $1.68 billion in 2025 at a compound annual growth rate (CAGR) of 15.7%. Growth during the historic period can be linked to increasing gene therapy research, greater use of viral vectors in clinical trials, rising outsourcing of vector production to CDMOs, expansion of cell and gene therapy pipelines, and a growing number of regulatory approvals for gene-based treatments.
The viral vector packaging services market size is expected to see rapid growth in the next few years. It will grow to $2.97 billion in 2029 at a compound annual growth rate (CAGR) of 15.3%. Growth in the forecast period can be attributed to rising investment in advanced biomanufacturing, increasing demand for high-quality, scalable vector production, greater emphasis on personalized and rare disease therapies, expanding commercialization of gene and cell therapies, and the growing need for GMP-compliant viral vector facilities. Key trends expected in the forecast period include advancements in vector engineering technologies, the development of scalable modular manufacturing platforms, innovations in high-yield upstream and downstream processes, and ongoing research into safer and more efficient viral delivery systems.
The growing demand for gene therapies is anticipated to drive the expansion of the viral vector packaging services market in the future. Gene therapies are treatments that involve introducing, removing, or modifying genetic material within a patient's cells to treat or prevent diseases. The demand for gene therapies is rising due to advancements in delivery systems, which enable the safe, efficient, and targeted delivery of genetic material into cells. Viral vector packaging services play a crucial role in gene therapy development by providing high-quality, ready-to-use viral vectors, which are essential for the efficient and reliable delivery of genetic material. These services help reduce development timelines and eliminate production bottlenecks by offering end-to-end solutions, which support the creation of advanced therapeutics and research tools. For example, in December 2024, the American Society of Gene & Cell Therapy (ASGCT), a U.S.-based non-profit organization, reported that the Food and Drug Administration (FDA) approved six gene therapy products in 2023, up from five approvals in 2022. As a result, the growing demand for gene therapies is driving the growth of the viral vector packaging services market.
Key companies in the viral vector packaging services market are focusing on the development of advanced products, such as lentiviral vector packaging systems. These systems are used to produce lentiviral vectors, which safely deliver genetic material into target cells for applications in gene therapy and research. For example, in June 2023, Charles River Laboratories International Inc., a U.S.-based contract research organization (CRO), introduced off-the-shelf lentiviral vector (LVV) packaging plasmids. This offering provides gene therapy developers with readily available, ready-to-use plasmid components that help reduce development timelines and production bottlenecks, making lentiviral vector manufacturing more efficient and cost-effective. This service is further supported by viral vector production services, which cover everything from clone construction to GMP-grade manufacturing for clinical and commercial use.
In December 2023, Ajinomoto Co. Inc., a Japan-based food and biotechnology company, acquired Forge Biologics Holdings LLC for an undisclosed amount. This acquisition allows Ajinomoto Co. to integrate its AminoScience technology platform with Forge's gene therapy CDMO capabilities to accelerate innovation in the treatment of rare diseases. The acquisition strengthens Ajinomoto's position in the advanced healthcare sector and supports its transition to a high-value-added business model aimed at long-term growth. Forge Biologics Holdings LLC, a U.S.-based contract development and manufacturing organization (CDMO), specializes in viral vector packaging services.
Major companies operating in the viral vector packaging services market are Novartis AG, Thermo Fisher Scientific Inc., Lonza Group AG, Charles River Laboratories International Inc., Catalent Inc., Takara Bio Inc., Aldevron LLC, FUJIFILM Diosynth Biotechnologies Inc., Oxford Biomedica PLC, OriGene Technologies Inc., Applied Biological Materials Inc., PackGene Co. Ltd., VectorBuilder Inc., ProMab Biotechnologies Inc., System Biosciences LLC (SBI), SignaGen Laboratories Inc., Cellecta Inc., Cell Biolabs Inc., WZ Biosciences Inc., Creative Biogene Co. Ltd.
North America was the largest region in the viral vector packaging services market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in viral vector packaging services report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the viral vector packaging services market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The viral vector packaging services market includes revenues earned by entities through vector design and optimization, cell line engineering, upstream processing, downstream purification, fill and finish services, stability testing, and sterility testing. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Viral Vector Packaging Services Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on viral vector packaging services market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for viral vector packaging services ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The viral vector packaging services market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.